Navigation Links
Health Decisions CEO Michael Rosenberg Named a Business Leader Top Entrepreneur for 2013
Date:5/6/2013

DURHAM, N.C., May 6, 2013 /PRNewswire-iReach/ -- Health Decisions, Inc., the leader in improving clinical trial efficiency, today announced that Business Leader Magazine named CEO Michael Rosenberg , MD, MPH one of its 2013 Top Entrepreneurs in the Triangle area of North Carolina, one of the leading biotechnology hubs in the United States. Dr. Rosenberg was honored at an awards dinner April 25 at the Brier Creek Country Club in Raleigh, NC.

(Photo: http://photos.prnewswire.com/prnh/20130506/CG07227)

"Business Leader once again is thrilled to present these very special awards to honor and recognize the Triangle's leading entrepreneurs," said Stephen Reynolds , publisher of Business Leader. "The Triangle has such a strong, successful and diverse entrepreneurial community. Whether serving those in need or working on breakthrough innovations in health care, these winners are changing people's lives. We thank each of our finalists for years of hard work and passion to make a difference."

"I'm honored to be recognized by Business Leader following an outstanding year at Health Decisions," Dr. Rosenberg said. "Health Decisions extended its leadership in clinical research in areas such as adaptive monitoring, where our proprietary solution enables us to reduce cost and improve data quality simultaneously. Entrepreneurial spirit throughout our company drives the innovation that allows us to conduct large trials with market-leading efficiency. A 12,000-patient study of a colorectal cancer diagnostic and a 3,500-patient global contraceptive study are recent examples."

Each year since 1996, Business Leader has honored executive leaders in the Triangle through its Top Entrepreneur Awards, recognizing those who have demonstrated exceptional leadership attributes and innovative approaches to enhance their company's industry status. Honorees for 2013 included Raleigh Mayor Nancy McFarlane , CEO of MedPro Rx, a specialized pharmacy services company, and James Petrilla , President and CEO of BioAgilytix Labs, a bioanalytics firm.

About Health Decisions

Health Decisions is the leading clinical research organization (CRO) in Agile Clinical Trials, providing proactive trial management based on real-time actionable information, enabling decisions that reduce timelines, accelerate access to new medicines and medical devices and allow biopharmaceutical and device companies to seize market opportunities. Founded in 1989, Health Decisions has conducted a range of successful clinical trials demonstrating means of reducing financial risk and time to market, including drugs and biologics, and devices. Health Decisions is headquartered in Durham, NC and operates on all five continents.

Media Contact: Leslie Hammill Health Decisions, 9199671111, lhammill@healthdec.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Health Decisions
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. inVentiv Health Selected to Provide Sales Operations Support for Santarus
6. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
7. Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs
8. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
9. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
10. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
11. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
Breaking Biology Technology:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
Breaking Biology News(10 mins):